These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24156652)

  • 1. Parkinson's disease, parkinsonism, and traumatic brain injury.
    Wong JC; Hazrati LN
    Crit Rev Clin Lab Sci; 2013; 50(4-5):103-6. PubMed ID: 24156652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Certain features of the clinical picture and pathomorphology of Parkinson disease of different etiology].
    Martynov IuS; Zenkevich GS; Tochilovskiĭ AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1033-9. PubMed ID: 7415721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
    Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM
    Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.
    Rinne JO; Rummukainen J; Paljärvi L; Rinne UK
    Ann Neurol; 1989 Jul; 26(1):47-50. PubMed ID: 2549846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traumatic brain injury and Alzheimer's disease: a review.
    Van Den Heuvel C; Thornton E; Vink R
    Prog Brain Res; 2007; 161():303-16. PubMed ID: 17618986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
    Schmidt WJ; Alam M
    J Neural Transm Suppl; 2006; (70):273-6. PubMed ID: 17017541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of Parkinson's disease in retired Thai traditional boxers.
    Lolekha P; Phanthumchinda K; Bhidayasiri R
    Mov Disord; 2010 Sep; 25(12):1895-901. PubMed ID: 20669292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pedunculopontine nucleus in Parkinson's disease.
    Zweig RM; Jankel WR; Hedreen JC; Mayeux R; Price DL
    Ann Neurol; 1989 Jul; 26(1):41-6. PubMed ID: 2549845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling neurodegenerative diseases in vivo review.
    von Bohlen Und Halbach O
    Neurodegener Dis; 2005; 2(6):313-20. PubMed ID: 16909014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
    Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI
    Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular parkinsonism.
    Sibon I; Tison F
    Curr Opin Neurol; 2004 Feb; 17(1):49-54. PubMed ID: 15090877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota.
    Chabolla DR; Maraganore DM; Ahlskog JE; O'Brien PC; Rocca WA
    Mayo Clin Proc; 1998 Aug; 73(8):724-7. PubMed ID: 9703296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry].
    Viñes JJ; Larumbe R; Gaminde I; Artázcoz MT
    Neurologia; 1999 Jan; 14(1):16-22. PubMed ID: 10079687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW
    Fortschr Neurol Psychiatr; 1989 Apr; 57(4):142-8. PubMed ID: 2656447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.